Getting latest data loading
Home / Morning Report / Morning Report – 3rd January 2023

This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.

Morning Report - 3 January 2023

Yesterday’s UK 100 Leaders Price (p) % Chg
Jd Sports Fashion PLC 126.2 2.4%
Coca-Cola Hbc AG 1,973.0 2.3%
Fresnillo PLC 901.8 1.9%
Scottish Mortgage Investment Trust PLC 722.8 1.0%
Next PLC 5,806.0 0.9%

 

Yesterday’s UK 100 Laggards Price (p) % Chg
Barratt Developments PLC 396.8 -3.1%
Persimmon PLC 1,217.0 -3.0%
Bt Group PLC 112.1 -2.7%
Ocado Group PLC 616.8 -2.6%
Rightmove PLC 511.4 -2.5%
Major World Indices Price % Chg 1 YEAR
UK 100 INDEX 7,452 -0.8% 0.9%
DOW JONES INDUS. AVG 33,147 -0.2% -8.8%
DAX INDEX 14,057 1.0% -11.5%
NIKKEI 225 26,095 0.0% -9.4%
S&P/ASX 200 INDEX 7,039 0.3% -5.5%
Commodities Units Price % Chg
WTI Crude Oil (Nymex) USD/bbl. 80.26 2.37%
Brent Crude (ICE) USD/bbl. 85.91 2.94%
Gold Spot USD/t oz. 1,824 0.5%
Copper (Comex) USd/lb. 381 -0.4%
The UK 100 called to open +40 points at 7492.

4 hours; 8 Months

Click graph to enlarge

Markets Overview:

The UK 100 called to open +40 points at 7492.   The UK’s bluechip index looks set to start the year on the front foot after the New Year holiday after European markets made progress yesterday and the Hang Seng advanced strongly today.  Although corporate news will likely be thin today, a number of PMI releases over the past couple of days may be of interest to investors, data showed further falls in manufacturing activity in China in Germany.

 

Company News & Broker Comments:

Company News:

Cineworld says they are not in talks with AMC Entertainment for sale of cinema assets.

 

 

Essentra appoints Scott Fawcett as CEO.

 

 

Hikma Pharmaceutical launches sodium oxybate medicine in the US for narcolepsy treatment.

 

 

Inchcape acquires Latin American automotive distributor Derco for £1.3bn.

 

 

Wizz Air carries 4.2m passengers in December at a 84.5% load factor. December traffic +58% and capacity +41% YoY.

 

 

Broker Comments:

 

Jefferies Downgrades SSE to Hold from Buy (8 Buys / 2 Holds / 0 Sells)

 

 

Jefferies Upgrades Rolls-Royce to Buy from Hold (1 Buy / 9 Holds / 1 Sell)

 

 

JP Morgan Downgrades GlaxoSmithKline to Underweight from Neutral (7 Buys / 12 Holds / 2 Sells)

 

 

JP Morgan Upgrades Hikma Pharmaceuticals to Overweight from Neutral (5 Buys / 4 Holds / 0 Sells)

Reporting Today:

Darktrace

Reporting Wednesday:

None

 

In Focus Today:

Chinese Caixin Manufacturing PMI

 

German Unemployment Change

 

UK S&P Global/CIPS Manufacturing PMI

 

German Harmonized Index of Consumer Prices

 

US S&P Global Manufacturing PMI

 

This Week's Ex-Dividends:

UK 100 companies going  ex-dividend on 5th January 2023:

 

 

Auto Trader Group

 

Experian

 

F&C Investment Trust

UK 250 companies going  ex-dividend on 29th December 2022:

 

 

Qinetiq Group

 

WH Smith

 

Workspace Group

 

Big Yellow Group

 

Dr. Martens

 

Murray International Trust

For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.


Back to Top

This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.


Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.

Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.
.